• Toggle Accessibility Statement
  • Home
  • Skip to Main Content
  • Sitemap
Menu
GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
  • AUXILIARY MENU
  • GOVPH
  • Home
  • About Us
    • The Pharmaceutical Division
    • Calendar of Events
  • Our Programs
    • COVID 19
    • Medicines Policy and Research
      • Advisory Council for the Implementation of RA 9502
      • Policy Dialogue on Universal Healthcare and Access to Medicines
      • Progress Report for the Implementation of the Cheaper Medicines Act of 2008
      • Research Management
    • Drug Pricing
      • Drug Price Database
      • Price Negotiation Board
      • Mark-up Regulation of Essential Medicines in DOH Facilities
    • Suggested Retail Price (SRP) for Selected Essential Emergency Medicines and Medical Devices
    • Botika ng Bayan and Botika ng Bayani
    • Rational Use of Medicines
      • Philippine National Formulary
      • DOH Program on Combating Antimicrobial Resistance
      • Active Drug Safety Monitoring and Management (aDSM) Program
  • Documents and Issuances
    • Laws
    • Official Issuances
    • Researches
    • Official Publications
      • Drug Price Reference Index Booklet
      • National Antibiotic Guidelines
      • The Philippine Action Plan to Combat Antimicrobial Resistance 2019-2023
      • Philippine National Formulary
      • Progress Report
  • Media Gallery
  • Links
    • Accessibility Statement
    • High Contrast
    • Skip to Content
    • Skip to Footer

(Department Circular No. 2021-0289) Exemption from Value-Added Tax of Certain Medicines Under Executive Order No.104

Exemption from Value-Added Tax of Certain Medicines Under Executive Order No.104 Related Posts Philippine Standard time Contact Us: Telephone Number: 02-8757734 Loc. 253 Address: 4th Floor, Philippine Blood Center, Lung continue reading : (Department Circular No. 2021-0289) Exemption from Value-Added Tax of Certain Medicines Under Executive Order No.104

Consolidated List of VAT Exempt Products under TRAIN and CREATE Law

Consolidated List of VAT Exempt Products under TRAIN and CREATE Law as of September 6, 2021 Related Posts No post Found cOvid 19 Updates 16 Nov 2020 Philippine Standard time continue reading : Consolidated List of VAT Exempt Products under TRAIN and CREATE Law